ATE333872T1 - Zusammensetzng auf diclofenac-basis für die topische behandlung von erkrankungen des oropharynx - Google Patents

Zusammensetzng auf diclofenac-basis für die topische behandlung von erkrankungen des oropharynx

Info

Publication number
ATE333872T1
ATE333872T1 AT03749856T AT03749856T ATE333872T1 AT E333872 T1 ATE333872 T1 AT E333872T1 AT 03749856 T AT03749856 T AT 03749856T AT 03749856 T AT03749856 T AT 03749856T AT E333872 T1 ATE333872 T1 AT E333872T1
Authority
AT
Austria
Prior art keywords
oropharynx
diclofenac
diseases
based composition
topical treatment
Prior art date
Application number
AT03749856T
Other languages
English (en)
Inventor
Mario Pinza
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Application granted granted Critical
Publication of ATE333872T1 publication Critical patent/ATE333872T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
AT03749856T 2002-05-10 2003-04-16 Zusammensetzng auf diclofenac-basis für die topische behandlung von erkrankungen des oropharynx ATE333872T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002MI000986A ITMI20020986A1 (it) 2002-05-10 2002-05-10 Composizione a base di diclofenac per il trattamento topico di affezioni del cavo orofaringeo

Publications (1)

Publication Number Publication Date
ATE333872T1 true ATE333872T1 (de) 2006-08-15

Family

ID=11449862

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03749856T ATE333872T1 (de) 2002-05-10 2003-04-16 Zusammensetzng auf diclofenac-basis für die topische behandlung von erkrankungen des oropharynx

Country Status (22)

Country Link
US (1) US20050100597A1 (de)
EP (1) EP1503747B1 (de)
JP (1) JP2005526120A (de)
KR (1) KR20040111415A (de)
CN (1) CN1303992C (de)
AR (1) AR039977A1 (de)
AT (1) ATE333872T1 (de)
AU (1) AU2003232480B2 (de)
CA (1) CA2477773C (de)
DE (1) DE60307086T2 (de)
DK (1) DK1503747T3 (de)
EA (1) EA006165B1 (de)
ES (1) ES2268402T3 (de)
GE (1) GEP20063822B (de)
HK (1) HK1071312A1 (de)
IL (2) IL163871A0 (de)
IT (1) ITMI20020986A1 (de)
MX (1) MXPA04010401A (de)
PL (1) PL215221B1 (de)
PT (1) PT1503747E (de)
UA (1) UA79110C2 (de)
WO (1) WO2003094905A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20032523A1 (it) 2003-12-19 2005-06-20 Acraf Forma di dosaggio per uso orale comprendente un farmaco
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
CN101138544B (zh) * 2006-09-06 2010-09-29 上海医药工业研究院 双氯芬酸或其盐局部成膜凝胶组合物及其应用
JP5432716B2 (ja) 2006-10-17 2014-03-05 ヌーボ リサーチ インコーポレイテッド ジクロフェナクゲル
US8618164B2 (en) 2009-03-31 2013-12-31 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
US8546450B1 (en) 2009-03-31 2013-10-01 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
US20120003162A1 (en) * 2010-06-30 2012-01-05 Mcneil-Ppc, Inc. Methods of Preparing Non-Alcohol Bioactive Esential Oil Mouth Rinses
KR101936192B1 (ko) * 2010-12-29 2019-01-08 엘지전자 주식회사 공기조화기의 실외기
DE102011111944A1 (de) * 2011-08-29 2013-02-28 Richard A. Huthmacher Verwendung von Diclofenac zur Verhinderung und Behandlung grippaler Infekte sowie durch grippale Infekte bewirkter Krankheitssymtome
US20150374745A1 (en) * 2014-06-30 2015-12-31 Mitochondrial Substrate Invention Limited Nutrients solutions for enhancement of cognitive function
CN104546527A (zh) * 2014-12-29 2015-04-29 福建省闽东力捷迅药业有限公司 一种含七叶皂苷钠的漱口液及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT370721B (de) * 1981-02-24 1983-04-25 Ciba Geigy Ag Verfahren zur herstellung von neuen salzen der 2- (2,6-dichloranilino)-phenylessigsaeure, der
EP0373103B1 (de) * 1988-11-10 1993-03-31 Ciba-Geigy Ag Flüssige orale Formulierung
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
US5028413A (en) * 1990-03-21 1991-07-02 Bausch & Lomb Incorporated Novel fluoride-containing dentifrice
IT1243342B (it) * 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
US5972906A (en) * 1991-07-03 1999-10-26 Hyal Pharmaceutical Corporation Treatment of mucous membrane disease, trauma or condition and for the relief of pain thereof
IT1250636B (it) * 1991-07-04 1995-04-21 Ricerche Di Schiena Del Dr Mic Sale del diclofenac, metodo di preparazione e composizioni farmaceutiche che lo contengono.
US5626838A (en) * 1995-03-13 1997-05-06 The Procter & Gamble Company Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx
CN1059797C (zh) * 1995-11-22 2000-12-27 王树力 双氯芬酸钠喷雾剂

Also Published As

Publication number Publication date
EA006165B1 (ru) 2005-10-27
ITMI20020986A0 (it) 2002-05-10
UA79110C2 (en) 2007-05-25
PT1503747E (pt) 2006-11-30
CN1303992C (zh) 2007-03-14
AU2003232480A1 (en) 2003-11-11
JP2005526120A (ja) 2005-09-02
US20050100597A1 (en) 2005-05-12
DE60307086D1 (de) 2006-09-07
MXPA04010401A (es) 2005-02-17
HK1071312A1 (en) 2005-07-15
PL371426A1 (en) 2005-06-13
DK1503747T3 (da) 2006-11-27
ITMI20020986A1 (it) 2003-11-10
ES2268402T3 (es) 2007-03-16
IL163871A (en) 2007-10-31
EP1503747B1 (de) 2006-07-26
AR039977A1 (es) 2005-03-09
WO2003094905A1 (en) 2003-11-20
CA2477773C (en) 2011-01-18
IL163871A0 (en) 2005-12-18
EA200401090A1 (ru) 2005-02-24
EP1503747A1 (de) 2005-02-09
DE60307086T2 (de) 2007-02-01
PL215221B1 (pl) 2013-11-29
GEP20063822B (en) 2006-05-10
KR20040111415A (ko) 2004-12-31
CA2477773A1 (en) 2003-11-20
AU2003232480B2 (en) 2008-07-31
CN1652763A (zh) 2005-08-10
WO2003094905A8 (en) 2004-04-01

Similar Documents

Publication Publication Date Title
DE60329123D1 (de) Benzoädüazepinderivate für die behandlung von neurologischen krankheiten
ATE374196T1 (de) Dihydrobenzodiazepin-2-on-derivative für die behandlung von neurologischen erkrankungen
DE60218493D1 (de) Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten
ATE439844T1 (de) Kombinationen für die behandlung entzündlicher erkrankungen
ATE424386T1 (de) Pyridin-verbindungen für die behandlung von prostaglandin-vermittelten krankheiten
ATE551340T1 (de) Azabicyclisch- substituierte annelierte heteroaryl-verbinungen für die behandlung von krankheiten
ATE286895T1 (de) Sulfonyl-pyrrolidinderivate geeignet für die behandlung von neurologischen krankheiten
DE60325498D1 (de) 1-acyl-pyrrolidin-derivate für die behandlung von viralen infektionen
DE60124576D1 (de) Verbindungen verwendbar für die behandlung von entzündungskrankheiten
DE60233069D1 (de) Zusammensetzungen aus curcuma extrakten für die behandlung von neurozerebrovaskulären erkrankungen
ATE512163T1 (de) Verabreichung von mitteln zur behandlung von entzündungen
ATE396202T1 (de) Lang wirkendes glucagon-ähnliches peptid-2 für die behandlung von gastrointestinalen krankheiten und störungen
ATE502642T1 (de) Kombinationen für die behandlung von immun- entzündlichen erkrankungen
DE60320007D1 (de) Phenethanolamin-derivate zur behandlung von atemwegserkrankungen
ATE478864T1 (de) Hydantoinderivate zur behandlung von entzündlichen erkrankungen
ATE440866T1 (de) Nogo-a-neutralisierende immunglobuline zur behandlung neurologischer krankheiten
DE60239218D1 (de) Synergistische zusammensetzungen für die behandlung von saatgut
ATE516037T1 (de) Topische formulierung von ivermectin zur behandlung von dermatologischen erkrankungen
DE60231107D1 (de) Tetrahydro-pyrazinoä1,2-aüindole für die behandlung von krankheiten des zentralnervensystems
ATE443704T1 (de) Pyridopyrimidinone zur behandlung von krebserkrankungen
DE602004023721D1 (de) Zusammensetzungen und methoden für die behandlung von herzerkrankungen
ATE333872T1 (de) Zusammensetzng auf diclofenac-basis für die topische behandlung von erkrankungen des oropharynx
ATE489361T1 (de) Derivate von alpha-phenylthiocarbon- und alpha- phenyloxycarbonsäuren, die für die behandlung von auf die aktivierung von ppar alpha ansprechende krankheiten geeignet sind
DE502004011696D1 (de) Behandlung bakterieller erkrankungen der atmungsorgane durch lokale applikation von fluorchinolonen
ATE391507T1 (de) S-methyl-dihydro-ziprasidone für die behandlung von schizophrenie

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1503747

Country of ref document: EP